Watch the recorded webinar: Dr. Moshe Ben-Shoshan introduces a unique patient education video on chronic spontaneous urticaria

See link below to a recording of the Sept 22 2021 webinar by Dr. Moshe Ben-Shoshan, Pediatric Allergy and Immunology Specialist, Montreal Children’s Hospital, in which he:

  • Introduces us to a 5:03 minute education video on CSU;
  • Shares the background and objectives of this educational tool;
  • Discusses the preliminary impact measurements on the patients’ counseling and his plan of action for the upcoming measurement steps
  • Assesses the willingness of some HIVE CoP members to take part in an upcoming measurement research project
  • Provides you with the link to download the video (available in English and in French), and use it with your own patients

>> View the video [27 min]

This program is made possible through the support of Novartis Pharmaceuticals Canada Inc. and is extended to Health Care Professional Members of the HIVE Virtual Community of Practice only.

The Buzz, Issue #7 is now out! In this issue we feature five new publications with high clinical relevance for Canadian allergists.

The Buzz Issue #7, September 2021 edition, will be sent to all HIVE members by email on Tuesday, September 14th, and can be accessed online here. This edition covers:

  • Challenges and success in implementing the findings from LEAP
  • Using graded oral challenge to confirm hypersensitivity to amoxicillin
  • Clinical and demographics characteristics of HAE patients in Canada
  • Comorbid autoimmune diseases in Type IIb autoimmune CSU
  • Review of urticarial vasculitis

To view all issues of The Buzz, go to thehivecommunity.org/the-buzz

Special Invitation to HIVE Members: Virtual-Live Presentation of a Unique Five-minute Patient Education Video on Chronic Spontaneous Urticaria

Dr. Moshe Ben-Shoshan, Pediatric Allergy and Immunology Specialist, Montreal Children’s Hospital, is pleased to invite you to attend a Virtual-Live Presentation of a Unique five-minute Patient Education Video on Chronic Spontaneous Urticaria (CSU)

September 22nd from 6:30pm Eastern Time

Dr. Ben-Shoshan would like to…

  1. Introduce you to the 5:03 minute video
  2. Share the background and objectives of this patient & family educational tool
  3. Discuss the preliminary impact measurements on the patients’ counseling and his plan of action for the upcoming measurement steps
  4. Assess the willingness of some HIVE CoP members to take part in an upcoming measurement research project of his
  5. Provide you with the link to download the video (available in English and in French), and use it with your own patients

We hope you will join this event.  

All HIVE members were sent an email on Tuesday, September 7th with a link to join the event.

If you did not receive a link to join or have any questions, you can reach out to Maryvonne Hamel, Medical Education manager at Novartis via e-mail maryvonne.hamel@novartis.com or phone 514 231-8758

This program is made possible through the support of Novartis Pharmaceuticals Canada Inc. and is extended to Health Care Professional Members of the HIVE Virtual Community of Practice only.

The Buzz, Issue #6 is now available, featuring five new publications with high clinical relevance for Canadian allergists.

The Buzz Issue #6, August edition, will be sent to all HIVE members by email on Monday, July 26, and can be accessed online here. This edition covers:

  • Seroconversion following vaccination for patients on anti-CD20 therapy
  • Association between meconium metabolome and atopy in Canadian infants
  • Context for a network meta-analysis of antihistamines in chronic spontaneous urticaria
  • Case series and systematic review of omalizumab for idiopathic anaphylaxis
  • Review on allergic rhinitis management

To view all issues of The Buzz, go to thehivecommunity.org/the-buzz

The Buzz, Issue #5 is now available! In this issue, we highlight new publications in urticaria, angioedema, asthma and draw attention to the new food allergy guidelines for childcare centres and schools.

The Buzz Issue #5, July edition, was sent to all HIVE members by email on Monday, June 28, and can be accessed online here. This edition covers:

  • Urticaria disease activity during and after pregnancy
  • A practical approach to identifying angioedema and urticaria mimics
  • Conditional recommendations on the prevention and management of allergic reactions in schools and childcare centers
  • Prestudy treatment effect on the SYGMA 1 and 2 outcomes

To view all issues of The Buzz, go to thehivecommunity.org/the-buzz

The Buzz, Issue #4 is now available! In this issue, we have five new articles to bring to the attention of Canadian allergists.

The Buzz Issue #4, June edition, was sent to all HIVE members by email on Monday, May 31, and can be accessed online here. This edition covers:

  • Pathogenic differentiation of CHA and CSU
  • Considerations for proceeding with or delaying the COViD-19 mRNA vaccine booster following a suspected anaphylactic event
  • Case reports of omalizumab exposure in pregnancy
  • Pediatric DRESS following penicillin-based therapy
  • Hereditary angioedema in the emergency department

To view all issues of The Buzz, go to thehivecommunity.org/the-buzz

The Buzz, Issue #3 is now available! In this issue, we highlight 5 new articles clinically relevant for Canadian allergists.

The Buzz Issue #3, May edition, was sent to all HIVE members by email on Monday, May 3, and can be accessed online here. This edition covers:

  • Evidence review in pediatric chronic spontaneous urticaria
  • An allergists guide to biologic economic analyses
  • Practical consensus recommendations for implementing oral immunotherapy
  • Updated contact dermatitis patch test results
  • Humoral immunity against SARS-CoV-2 in Canadian patients

To view all issues of The Buzz, go to thehivecommunity.org/the-buzz

The Buzz, Issue #2 is now available! Check out this month’s selection of new publications clinically relevant to Canadian allergists, immunologists and dermatologists.

The Buzz Issue #2, April edition, was sent to all HIVE members by email on Monday, March 29, and can be accessed online here. This edition covers:

  • The allergists’ perspective on anaphylaxis risk with SARS-CoV-2 vaccines
  • Emerging biologics for chronic spontaneous urticaria
  • Predictors of response and non-response in chronic spontaneous urticaria
  • Real-world analysis of omalizumab in chronic inducible urticaria
  • Quantifying peanut allergen thresholds in Canadian children and young adults

To view all issues of The Buzz, go to thehivecommunity.org/the-buzz

Introducing “The Buzz”, a monthly feature of the HIVE community where recent articles are selected and summarized for clinical relevance to Canadian allergists, immunologists and dermatologists

We’re delighted to introduce a new feature of the HIVE community – The Buzz!

The Buzz is a monthly selection of new publications clinically relevant to the HIVE community of Canadian allergists, immunologists and dermatologists.

The Buzz will be sent to all HIVE members by email each month, with highlights in the weekly HIVE email digests. View all issues of The Buzz online here.